Projects that will be considered for support under this grant program will focus on increasing the understanding of PARP inhibitors and the future of their use in the treatment of advanced prostate cancer. Topics of interest include Mechanisms of Action of PARP inhibitors, selection of appropriate patients, biomarker testing process, analytical platforms and result interpretation to inform decision-making, and management of patients treated with PARP inhibitors.
Funding & Duration
Funding of up to US $150,000 (approx. AUD $218,000) will be considered, for a maximum period of two years.
- View Program Guidelines (PDF) for full eligibility details
Submission Requirements & Due Date
- Applications must be submitted for internal review by 23 October 2019.
- Please email email@example.com if you are considering applying for this scheme.
- See also: Submitting an Application to Research Services for Review